There may soon be more treatment options for patients living with stage four cancers.
For patients whose cancer has metastasized, the options can be limited. While new drugs are being developed, they are often only approved for a specific subset or stage of cancer—sometimes even a specific age group. However, researchers are looking to expand on a pool of patients that can get these new drugs.
Dr. Sara Hurvitz, the director of the Breast Cancer Research Program at UCLA, joins Ira to talk about how a drug that was approved for breast cancer in postmenopausal women may soon be available for younger patients.
Also joining Ira is Dr. Neeraj Agarwal, the director of the Genitourinary Oncology Program at the Huntsman Cancer Institute, to talk about a new treatment option for patients with metastatic prostate cancer.
|Read on: Making Cancer Drugs Available For A Wider Pool Of Patients|